Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

1.

Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection.

Chen X, Zhang B, Yin X, Ren Z, Qiu S, Zhou J.

J Cancer Res Clin Oncol. 2013 May;139(5):773-81. doi: 10.1007/s00432-012-1343-7. Epub 2013 Feb 3.

PMID:
23377952
[PubMed - indexed for MEDLINE]
2.

[Effect of postoperative adjuvant transarterial chemoembolization upon early recurrence after radical resection of hepatocellular carcinoma].

Chen XH, Zhang BH, Yin X, Qiu SJ, Fan J, Ren ZG, Xia JL, Wang YH, Ye SL, Gan YH.

Zhonghua Yi Xue Za Zhi. 2010 Mar 30;90(12):826-9. Chinese.

PMID:
20450622
[PubMed - indexed for MEDLINE]
3.

Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.

Eguchi S, Matsumoto S, Hamasaki K, Takatsuki M, Hidaka M, Tajima Y, Sakamoto I, Kanematsu T.

J Hepatobiliary Pancreat Surg. 2008;15(6):627-33. doi: 10.1007/s00534-007-1341-3. Epub 2008 Nov 7.

PMID:
18987934
[PubMed - indexed for MEDLINE]
4.

Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: a non-randomized comparative study.

Xi T, Lai EC, Min AR, Shi LH, Wu D, Xue F, Wang K, Yan Z, Xia Y, Shen F, Lau WY, Wu MC.

Hepatogastroenterology. 2012 Jun;59(116):1198-203. doi: 10.5754/hge09654.

PMID:
22580673
[PubMed - indexed for MEDLINE]
5.

Predisposing factors of hepatocellular carcinoma recurrence following complete remission in response to transarterial chemoembolization.

Jin YJ, Chung YH, Kim JA, Park W, Lee D, Shim JH, Lee D, Kim KM, Lim YS, Lee HC, Lee YS, Kim PN, Sung KB.

Dig Dis Sci. 2013 Jun;58(6):1758-65. doi: 10.1007/s10620-013-2562-8. Epub 2013 Jan 30.

PMID:
23361574
[PubMed - indexed for MEDLINE]
6.

Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelines.

Takayasu K, Arii S, Kudo M, Ichida T, Matsui O, Izumi N, Matsuyama Y, Sakamoto M, Nakashima O, Ku Y, Kokudo N, Makuuchi M.

J Hepatol. 2012 Apr;56(4):886-92. doi: 10.1016/j.jhep.2011.10.021. Epub 2011 Dec 13.

PMID:
22173160
[PubMed - indexed for MEDLINE]
7.

Superselective transarterial chemoembolization vs hepatic resection for resectable early-stage hepatocellular carcinoma in patients with Child-Pugh class a liver function.

Hsu KF, Chu CH, Chan DC, Yu JC, Shih ML, Hsieh HF, Hsieh TY, Yu CY, Hsieh CB.

Eur J Radiol. 2012 Mar;81(3):466-71. doi: 10.1016/j.ejrad.2010.12.058. Epub 2011 Mar 3.

PMID:
21376495
[PubMed - indexed for MEDLINE]
8.

Complete necrosis after transarterial chemoembolization could predict prolonged survival in patients with recurrent intrahepatic hepatocellular carcinoma after curative resection.

Shim JH, Kim KM, Lee YJ, Ko GY, Yoon HK, Sung KB, Park KM, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ.

Ann Surg Oncol. 2010 Mar;17(3):869-77. doi: 10.1245/s10434-009-0788-7. Epub 2009 Dec 22.

PMID:
20033326
[PubMed - indexed for MEDLINE]
9.

Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma?

Choi GH, Kim DH, Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR.

World J Surg. 2007 Dec;31(12):2370-7.

PMID:
17912587
[PubMed - indexed for MEDLINE]
10.

Clinical significance and risk factors of postembolization fever in patients with hepatocellular carcinoma.

Jun CH, Ki HS, Lee HK, Park KJ, Park SY, Cho SB, Park CH, Joo YE, Kim HS, Choi SK, Rew JS.

World J Gastroenterol. 2013 Jan 14;19(2):284-9. doi: 10.3748/wjg.v19.i2.284.

PMID:
23345952
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection.

Choi JW, Park JY, Ahn SH, Yoon KT, Ko HK, Lee do Y, Lee JT, Kim KS, Choi JS, Han KH, Chon CY, Kim do Y.

Am J Clin Oncol. 2009 Dec;32(6):564-9. doi: 10.1097/COC.0b013e3181967da0.

PMID:
19564783
[PubMed - indexed for MEDLINE]
12.

Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study.

Ren ZG, Lin ZY, Xia JL, Ye SL, Ma ZC, Ye QH, Qin LX, Wu ZQ, Fan J, Tang ZY.

World J Gastroenterol. 2004 Oct 1;10(19):2791-4.

PMID:
15334671
[PubMed - indexed for MEDLINE]
Free Article
13.

Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.

Stockland AH, Walser EM, Paz-Fumagalli R, McKinney JM, May GR.

Cardiovasc Intervent Radiol. 2007 Sep-Oct;30(5):888-93.

PMID:
17619218
[PubMed - indexed for MEDLINE]
14.

Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis.

Luo J, Peng ZW, Guo RP, Zhang YQ, Li JQ, Chen MS, Shi M.

Radiology. 2011 Apr;259(1):286-95. doi: 10.1148/radiol.10101072. Epub 2011 Feb 17.

PMID:
21330557
[PubMed - indexed for MEDLINE]
15.

Surgery versus transarterial chemoembolization for solitary large hepatocellular carcinoma of BCLC stage A.

Jin YJ, Lee JW, Choi YJ, Chung HJ, Kim YS, Lee KY, Ahn SI, Shin WY, Cho SG, Jeon YS.

J Gastrointest Surg. 2014 Mar;18(3):555-61. doi: 10.1007/s11605-013-2440-x. Epub 2014 Jan 14.

PMID:
24420729
[PubMed - indexed for MEDLINE]
16.

Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma.

Kang JY, Choi MS, Kim SJ, Kil JS, Lee JH, Koh KC, Paik SW, Yoo BC.

Korean J Hepatol. 2010 Dec;16(4):383-8. doi: 10.3350/kjhep.2010.16.4.383.

PMID:
21415582
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

[Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].

Lin Z, Ren Z, Xia J.

Zhonghua Zhong Liu Za Zhi. 2000 Jul;22(4):315-7. Chinese.

PMID:
11778559
[PubMed - indexed for MEDLINE]
18.

Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma.

Takaki S, Sakaguchi H, Anai H, Tanaka T, Yamamoto K, Morimoto K, Nishiofuku H, Inoue M, Sueyoshi S, Nagata T, Hidaka T, Uchida H, Kichikawa K.

Cardiovasc Intervent Radiol. 2012 Jun;35(3):544-54. doi: 10.1007/s00270-011-0224-9. Epub 2011 Jul 8.

PMID:
21739345
[PubMed - indexed for MEDLINE]
19.

Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.

Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Park JH, Suh DJ.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):2004-11. doi: 10.1016/j.ijrobp.2011.03.019. Epub 2011 May 27.

PMID:
21621346
[PubMed - indexed for MEDLINE]
20.

Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.

Jin YJ, Lee JW, Lee OH, Chung HJ, Kim YS, Lee JI, Cho SG, Jeon YS, Lee KY, Ahn SI, Shin WY.

J Gastroenterol Hepatol. 2014 May;29(5):1056-64. doi: 10.1111/jgh.12507.

PMID:
24372785
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk